Elevated serum uric acid as an independent risk factor for multiple stent placement in non-hypertensive, non-diabetic patients with coronary artery disease: a retrospective cohort analysis.
Qingyan Li, Jianguo Li, Mengwen Niu, Tianshu Chu, Lemei An
{"title":"Elevated serum uric acid as an independent risk factor for multiple stent placement in non-hypertensive, non-diabetic patients with coronary artery disease: a retrospective cohort analysis.","authors":"Qingyan Li, Jianguo Li, Mengwen Niu, Tianshu Chu, Lemei An","doi":"10.1007/s10067-025-07602-w","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>While the relationship between serum uric acid (SUA) and coronary artery disease (CAD) remains controversial, emerging evidence suggests a particularly significant association in patients lacking traditional cardiovascular risk factors. The specific role of hyperuricemia in determining CAD severity in non-hypertensive, non-diabetic populations warrants further investigation.</p><p><strong>Methods: </strong>In this retrospective cohort study, we analyzed 716 consecutive CAD patients undergoing percutaneous coronary intervention (PCI), with a focus on 279 individuals without hypertension or diabetes. We employed multivariable logistic regression and stratified analyses to assess the independent association between SUA levels and multiple stent implantation (≥ 2 stents), a robust indicator of CAD complexity, and prognosis. Hyperuricemia was defined using gender-specific thresholds (> 420 μmol/L for males and postmenopausal females; > 360 μmol/L for premenopausal females).</p><p><strong>Results: </strong>In the overall cohort, multivessel disease (OR = 2.27, 95% CI 1.94-3.96, p < 0.001) and diabetes (OR = 1.47, 95% CI 1.05-2.07, p = 0.027) independently predicted multiple stent placement. Notably, in the non-hypertensive, non-diabetic subgroup, hyperuricemia emerged as a strong independent predictor (OR = 4.62, 95% CI 1.93-11.07, p = 0.001), exceeding the predictive value of multivessel disease (OR = 3.16, 95% CI 1.78-5.55, p < 0.001). No significant association was observed between SUA levels and stent number in the broader cohort.</p><p><strong>Conclusions: </strong>Elevated serum uric acid independently predicts complex coronary lesions requiring multiple stent placements in non-hypertensive, non-diabetic CAD patients. These findings suggest that uric acid assessment may enhance risk stratification in this specific patient population, warranting further investigation into its clinical implications. Key Points • Elevated serum uric acid is an independent predictor of complex coronary lesions requiring multiple stent placements in non-hypertensive, non-diabetic patients with coronary artery disease, highlighting its potential role in risk stratification for this specific population.</p>","PeriodicalId":10482,"journal":{"name":"Clinical Rheumatology","volume":" ","pages":""},"PeriodicalIF":2.8000,"publicationDate":"2025-09-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinical Rheumatology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1007/s10067-025-07602-w","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"RHEUMATOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Background: While the relationship between serum uric acid (SUA) and coronary artery disease (CAD) remains controversial, emerging evidence suggests a particularly significant association in patients lacking traditional cardiovascular risk factors. The specific role of hyperuricemia in determining CAD severity in non-hypertensive, non-diabetic populations warrants further investigation.
Methods: In this retrospective cohort study, we analyzed 716 consecutive CAD patients undergoing percutaneous coronary intervention (PCI), with a focus on 279 individuals without hypertension or diabetes. We employed multivariable logistic regression and stratified analyses to assess the independent association between SUA levels and multiple stent implantation (≥ 2 stents), a robust indicator of CAD complexity, and prognosis. Hyperuricemia was defined using gender-specific thresholds (> 420 μmol/L for males and postmenopausal females; > 360 μmol/L for premenopausal females).
Results: In the overall cohort, multivessel disease (OR = 2.27, 95% CI 1.94-3.96, p < 0.001) and diabetes (OR = 1.47, 95% CI 1.05-2.07, p = 0.027) independently predicted multiple stent placement. Notably, in the non-hypertensive, non-diabetic subgroup, hyperuricemia emerged as a strong independent predictor (OR = 4.62, 95% CI 1.93-11.07, p = 0.001), exceeding the predictive value of multivessel disease (OR = 3.16, 95% CI 1.78-5.55, p < 0.001). No significant association was observed between SUA levels and stent number in the broader cohort.
Conclusions: Elevated serum uric acid independently predicts complex coronary lesions requiring multiple stent placements in non-hypertensive, non-diabetic CAD patients. These findings suggest that uric acid assessment may enhance risk stratification in this specific patient population, warranting further investigation into its clinical implications. Key Points • Elevated serum uric acid is an independent predictor of complex coronary lesions requiring multiple stent placements in non-hypertensive, non-diabetic patients with coronary artery disease, highlighting its potential role in risk stratification for this specific population.
期刊介绍:
Clinical Rheumatology is an international English-language journal devoted to publishing original clinical investigation and research in the general field of rheumatology with accent on clinical aspects at postgraduate level.
The journal succeeds Acta Rheumatologica Belgica, originally founded in 1945 as the official journal of the Belgian Rheumatology Society. Clinical Rheumatology aims to cover all modern trends in clinical and experimental research as well as the management and evaluation of diagnostic and treatment procedures connected with the inflammatory, immunologic, metabolic, genetic and degenerative soft and hard connective tissue diseases.